Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SERBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAAP20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIPF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CINP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PXYLP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GXYLT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D10A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNAPC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAMD4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDST4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NLRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on